CD103+ DC progenitors activate and expand through the systemic administration of FLT3L followed by intratumoral polyI:C injections with the administration of immune checkpoint blockade enhancing the anti-tumoral effect and limiting tumor growth [171]. This evidence concerns the gene ITGAE and neoplasm.